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Abstract
Background: Several techniques have been discussed as alternatives to the intermittent bolus thermodilution
cardiac output (COPAC) measurement by the pulmonary artery catheter (PAC). However, these techniques
usually require a central venous line, an additional catheter, or a special calibration procedure. A new arterial
pressure-based cardiac output (COAP) device (FloTrac™, Vigileo™; Edwards Lifesciences, Irvine, CA, USA) only
requires access to the radial or femoral artery using a standard arterial catheter and does not need an external
calibration. We validated this technique in critically ill patients in the intensive care unit (ICU) using COPAC as the
method of reference.
Methods: We studied 20 critically ill patients, aged 16 to 74 years (mean, 55.5 ± 18.8 years), who required both
arterial and pulmonary artery pressure monitoring. COPAC measurements were performed at least every 4 hours
and calculated as the average of 3 measurements, while COAP values were taken immediately at the end of bolus
determinations. Accuracy of measurements was assessed by calculating the bias and limits of agreement using the
method described by Bland and Altman.
Results: A total of 164 coupled measurements were obtained. Absolute values of COPAC ranged from 2.80 to
10.80 l/min (mean 5.93 ± 1.55 l/min). The bias and limits of agreement between COPAC and COAP for unequal
numbers of replicates was 0.02 ± 2.92 l/min. The percentage error between COPAC and COAP was 49.3%. The
bias between percentage changes in COPAC (ΔCOPAC) and percentage changes in COAP (ΔCOAP) for consecutive
measurements was -0.70% ± 32.28%. COPAC and COAP showed a Pearson correlation coefficient of 0.58 (p <
0.01), while the correlation coefficient between ΔCOPAC and ΔCOAP was 0.46 (p < 0.01).
Conclusion: Although the COAP algorithm shows a minimal bias with COPAC over a wide range of values in an
inhomogeneous group of critically ill patients, the scattering of the data remains relative wide. Therefore, the used
algorithm (V 1.03) failed to demonstrate an acceptable accuracy in comparison to the clinical standard of cardiac
output determination.
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Background
Accurate evaluation of cardiac performance is an impor-
tant goal in the treatment of critically ill patients. Usually
a pulmonary artery catheter (PAC) is placed for assess-
ment of cardiac output (CO), but as a result of the current
discussion about the usefulness and risks of the PAC [1,2],
several less invasive techniques have been discussed as
alternatives to the intermittent bolus thermodilution car-
diac output (COPAC) measurement by the PAC [3], which
still represents the clinical standard.
Particularly techniques using arterial waveform analysis
for CO assessment (PiCCOplus®, Pulsion Medical Systems,
Munich, Germany and LiDCO™plus, LiDCO Ltd, Cam-
bridge, UK) have been tested as alternatives to the PAC,
partly with excellent results [4-10]. However, these tech-
niques usually require an additional catheter, a central
venous line, or a special calibration procedure such as
transpulmonary thermodilution (PiCCOplus®) or lithium
dilution (LiDCO™plus). Furthermore, the inability of
these devices to compensate for changes in individual aor-
tic input impedance or central aortic compliance, which
both may alter the calculated CO by the pulse contour
technique in hemodynamic instability, can lead to errone-
ous assessment of CO [11,12].
A new arterial pressure-based cardiac output (COAP)
device (FloTrac™, Vigileo™; Edwards Lifesciences, Irvine,
CA, USA) only requires access to the radial or femoral
artery using a standard arterial catheter and does not need
an external calibration. To facilitate COAP assessment by
arterial pulse waveform analysis without an external cali-
bration mode, the system estimates individual arterial
compliance according to Langewouters five component
model [13] and continuously compensates for changes in
vascular tone by detecting characteristic alterations in the
arterial pressure waveform. But until now there has been
only limited information about the value of this new
device [14-16].
Therefore, this study was performed to evaluate the accu-
racy of FloTrac™-derived COAP assessment in an inhomo-
geneous group of critically ill patients in a neurosurgical
intensive care unit (ICU) using COPAC as the method of
reference.
Methods
After obtaining approval of the Institutional Ethics Com-
mittee of the University of Regensburg Medical Centre
(Regensburg, Germany) and with written informed con-
sent from the patient or their relative, we studied 20 criti-
cally ill patients (10 male), aged 16 to 74 years (mean,
55.5 ± 18.8 years) in a neurosurgical ICU, who due to the
severity of their illness required both, arterial and pulmo-
nary artery pressure monitoring. Patients with intracardiac
shunts or peripheral vascular disease were excluded from
the study.
Analgesia based sedation was maintained with an infu-
sion of fentanyl of 1.5–4.5 mg·kg-1·h-1 and midazolam of
0.15–0.35 mg·kg-1·h-1, supplemented with an infusion
of ketamine of 1.5–4.0 mg·kg-1·h-1 in some patients.
Pressure controlled ventilation (BiLevel®-mode, Bennett
840 ™ Ventilator System, Puritan Bennett, Pleasanton, CA,
USA) with a positive end expiratory pressure of 5–15
mmHg and a tidal volume of 6–8 ml/kg to an end tidal
pCO2 of 32–38 mmHg was maintained throughout the
study.
All patients received a radial arterial line for continuous
monitoring of arterial blood pressure (Siemens monitor
SC 9000, Erlangen, Germany). A 7.5F pulmonary artery
catheter (Baxter Healthcare Corporation, Irvine, CA, USA)
was inserted via an 8.5 F introducer into the internal jug-
ular or subclavian vein for intermittent thermodilution
cardiac output (COPAC) measurement (Siemens monitor
SC 9000, Erlangen, Germany). COPAC measurements were
performed at least every 4 hours by injection of 10 ml iced
saline solution via the CVP port of the PAC and subse-
quent detection by the thermistor embedded into the
PAC. The average of 3 measurements, all measured within
a 15% range randomly distributed over the respiratory
cycle, was calculated according to the Stewart-Hamilton
formula. If there was more than 15% variation between
the values, five measurements were performed, the high-
est and lowest values from CO calculation were excluded,
and the remaining three values averaged.
The FloTrac™sensor was attached to the existing arterial
line and connected to the Vigileo™monitor for arterial
pressure-based COAP assessment. Following initiation of
the Vigileo™monitor by entering patient's age, gender,
height and weight, the system computes stroke volume
(SV) from the patients arterial pressure signal and displays
COAP continuously.
The methodology of arterial pressure-based COAP assess-
ment by the FloTrac™system has been previously
described by Manecke [17] and involves the calculation of
SV regarding the proven relationship between pulse pres-
sure (PP, the difference between systolic and diastolic
blood pressure) and SV [18,19]. As demonstrated by Bou-
lain, aortic PP is proportional to SV and is inversely
related to aortic compliance for a given SV [18]. Based
upon this physiological principle, the FloTrac™device
assesses the arterial pulse waveform at a sampling rate of
100 Hz over a 20 second period, which generates approx-
imately 2000 data points, and calculates the standard
deviation (SDAP) of each measured beat to provide a
robust assessment of key PP characteristics. Calculation of
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SDAP should be more precisely related to SV, in that
multiple values are measured to determine the variability,
rather than a simple single PP measurement [20]. SDAP
of the arterial pressure waveform is computed on a beat-
to-beat basis using the following equation:
where AP(k) is the kth pulse pressure sample in the current
beat, N is the total number of samples, and APmean is the
mean of arterial pressure [21]. To continuously compen-
sate for changes in vascular compliance and peripheral
resistance, a scale factor χ is calculated on the basis of bio-
metric data [13] and the analysis of characteristic altera-
tions of the individual arterial pressure waveform, such as
skewness or kurtosis, reflecting changes in vascular tone.
In the used version of software (V 1.03), χ was recalcu-
lated every 10 minutes. Thus, COAP is computed as:
COAP = HR • SDAP • χ
where HR is the heart rate and χ a scale factor propor-
tional to vascular compliance and peripheral resistance.
FloTrac™-derived COAP values were taken immediately at
the end of bolus determinations, representing an average
over the last minutes. Measurements were completed
when the PAC or the arterial catheter was removed, or the
patient was weaned from mechanical ventilation.
Statistical Analysis
The bias between COPAC and COAP for all values and for
percentage changes (Δ = trend analysis) between consecu-
tive CO determinations was calculated as the mean differ-
ence between measurements and expresses the agreement
between methods. To avoid a systematical calculation
error in the case of repeated measurements per subject, the
bias between methods was calculated according to a mod-
ified statistical approach by Bland and Altman for une-
qual numbers of replicates [22]. The upper and lower
limits of agreement (LOA), defining the range in which
95% of the differences between methods are expected to
lie, were calculated as bias ± 1.96 SD. The bias and the
LOA are reported as 95% confidence interval. The percent-
age error, defined as the standard deviation of the bias (±
1.96 SD) divided by the mean CO, was calculated accord-
ing to Critchley and Critchley [23]. The acceptable limit of
variability between techniques was determined as a per-
centage error below ± 30%. Linear regression analysis was
performed between the absolute values of COPAC and
COAP and between percentage changes in COPAC and
COAP. A p < 0.05 was regarded as significant.
Results
Demographic data, patient characteristics and the number
of measurement repetitions per patient are presented in
Table 1.
A total of 164 coupled measurements were obtained.
Absolute values of COPAC ranged from 2.80 to 10.80 l/min
(mean 5.93 ± 1.55 l/min), while absolute values of COAP
ranged from 3.40 to 9.80 l/min (mean 5.91 ± 1.15 l/min).
The modified Bland-Altman analysis for an unequal
number of replicates between COPAC and COAP showed a
mean bias and LOA of 0.02 ± 2.92 l/min (Figure 1A). The
percentage error between COPAC and COAP was 49.3%.
COPAC and COAP showed a correlation coefficient of 0.58
(p < 0.01) as displayed in Figure 1B.
A total of 144 coupled measurements were obtained for a
trend analysis of percentage changes in CO. The bias
between percentage changes in COPAC (ΔCOPAC) and per-
centage changes in COAP (ΔCOAP) for consecutive meas-
urements was -0.70% with LOA of ± 32.28% (Figure 2A).
ΔCOPAC and ΔCOAP revealed a correlation coefficient of
0.46 (p < 0.01) as shown in Figure 2B.
The results of the analysis of agreement, assessed by bias,
and the distribution of the observed differences, indicated
by bias ± 1.96 SD as upper and lower LOA including 95%
confidence intervals are presented in Table 2.
Discussion
This should be the first investigation evaluating a new
arterial pressure-based CO-device in an inhomogeneous
group of critically ill patients on a neurosurgical ICU in
comparison to the clinical standard of CO determination.
The fact that all patients received pulmonary artery pres-
sure monitoring due to the severity of their illness differ-
entiates our trial from previous studies, which all
evaluated FloTrac-system in elective cardiac surgical
patients, representing a relatively homogeneous, hemody-
namically stable and artificial group of patients in which
pulmonary artery pressure monitoring is not necessarily
performed.
The results of the present study demonstrate a minimal
bias between the absolute values of COPAC and COAP over
a large range of values in an inhomogeneous group of crit-
ically ill patients. However, a relative wide scattering of
the data could be observed, possibly due to the calcula-
tion mode with which the algorithm compensates for
changes in vascular tone.
Several studies have shown that less invasive devices for
CO assessment based on arterial waveform analysis,
such as PiCCOplus® or LiDCO™plus, are valuable alterna-
tives to the intermittent thermodilution technique by the
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PAC [4-10]. However, all these techniques require an
additional catheter, a central venous line, or an external
calibration procedure. Furthermore, the inability of these
techniques to continuously compensate for changes in
vascular tone during hemodynamic instability [12] with
the consequential need of frequent recalibrations invali-
dates strictly speaking the claim of a continuously meas-
uring device. Therefore, finding a minimal invasive device
for accurate and continuous CO assessment, which is sim-
ple to handle and independent of an additional catheter
and an external calibration mode, is still of constant
clinical interest.
The recently introduced FloTrac™system should be an
interesting alternative for CO assessment and may have
potential advantages due to its relative non-invasiveness
and simplicity, but until now there has been only limited
information about the value of this new device [14-16].
Opdam and colleagues recently studied six patients after
elective cardiac surgery and stated that the cardiac index
(CI) values obtained with the FloTrac™system were impre-
cise compared with the PAC because of an inconsistent
bias (0.21 l·min-1·m2) and a wide scattering of data
(± 1.02 l·min-1·m2) [15]. However, major limitations of
that study were the small number of patients included
Table 1: Demographic data and patient characteristics
Patient Diagnosis Age (years) Sex Apache II Score BMI (kg/m2) Measurements (n)
1 ICB, Acute heart 
failure
70 female 37 34.3 20
2 Cerebral infarct, 
Angina pectoris
73 female 36 27.3 6
3 Craniocerebral 
injury
21 male 14 27.7 5
4 SAH 46 female 12 19.6 7
5 Craniocerebral 
injury, Thorax 
trauma
18 male 28 19.0 8
6 SAH, Cerebral 
infarct
49 female 26 25.8 8
7 Sepsis 62 male 37 31.4 6
8 SAH 66 male 21 28.4 15
9 PAH 71 female 17 28.6 6
10 ICB, Hypertension 49 female 21 24.5 14
11 Craniocerebral 
injury, 
Cardiopulmonary 
resuscitation
16 female 31 23.9 7
12 Coronary heart 
disease, CABG
71 male 29 31.1 5
13 Mitral 
regurgitation, MVR
74 male 37 33.0 4
14 SAH, ICB 43 female 23 22.8 13
15 Coronary heart 
disease, Mitral 
regurgitation, 
CABG, MVR
64 male 12 22.4 3
16 Coronary heart 
disease, CABG
69 male 20 28.3 8
17 Cerebral infarct 73 female 32 35.9 7
18 SAH, Pulmonary 
edema
53 male 27 26.4 8
19 Intracranial 
haematoma
70 male 20 33.1 11
20 Sepsis, 
Cardiopulmonary 
resuscitation
52 female 34 24.2 3
all 55.5 ± 18.9 10 male 25.7 ± 8.4 27.4 ± 4.7 164
Data are presented as mean ± SD or as frequency distributions (n) and simple percentages (%).
Appreviations: BMI = body mass index; CABG = coronary artery bypass grafting; ICB = intracerebral bleeding; MVR = mitral valve replacement; 
PAH = pulmonary arterial hypertension; SAH = subarachnoidal haemorrhage.
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Bland-Altman plot (A) and regression analysis (B) for comparison between the intermittent thermodilution-derived cardiac output (COPAC) by the pulmonary artery catheter (PAC) and the arterial pressure-based cardiac output (COAP) by the FloTrac™system for unequal umbers of replicatesigure 1
Bland-Altman plot (A) and regression analysis (B) for comparison between the intermittent thermodilution-derived cardiac 
output (COPAC) by the pulmonary artery catheter (PAC) and the arterial pressure-based cardiac output (COAP) by the 
FloTrac™system for unequal numbers of replicates. The solid line represents the mean difference (bias) and the dashed lines 
represent the limits of agreement (bias ± 1.96 SD).
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Bland-Altman plot (A) and regression analysis (B) for comparison between the percentage changes in intermittent thermodi-lution derived cardiac output (ΔCOPAC) by the pulmonary artery cathet r (PAC) and arterial pressure-based cardiac output (ΔCOAP) by the FloTrac™system for consecutive easurementsFigure 2
Bland-Altman plot (A) and regression analysis (B) for comparison between the percentage changes in intermittent thermodi-
lution-derived cardiac output (ΔCOPAC) by the pulmonary artery catheter (PAC) and arterial pressure-based cardiac output 
(ΔCOAP) by the FloTrac™system for consecutive measurements. The solid line represents the mean difference (bias) and the 
dashed lines represent the limits of agreement (bias ± 1.96 SD).
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(6 patients), the extremely varying replicates of CO deter-
minations obtained for each patient (8 vs. 158) and an
inadequate statistical method. Not using the modified sta-
tistical approach by Bland and Altman for unequal num-
bers of replicates in comparison studies may falsify any
result in an unpredictable manner. Variability of measure-
ments made on different subjects is usually much greater
than the variability between measurements on the same
subject, and this phenomenon should be taken into
account. In the worst case the findings may merely reflect
the results of the patient with the majority of measuring
repetitions.
Sander and co-workers compared 30 CABG patients at
four different time points and demonstrated that CO
measurements by the FloTrac™system showed a high bias
(0.6 l/min, with a percentage error of 54%) and a wide
range of LOA (± 2.8 l/min) in comparison with the COPAC
measurement [16]. The authors suggest that CO assess-
ment with pulse contour analysis techniques in a setting
after cardiac surgery basically might not be the ideal
method. Similar results were recently reported by Mayer et
al, who found a bias and LOA of 0.46 ± 1.15 l·min-1·m2
with a percentage error of 46% for CI comparisons
between methods in 40 cardiac surgical patients [14].
Our results are in accordance with the findings of the very
limited number of publications regarding the accuracy of
COAP assessment and also revealed a relative wide scatter-
ing of data as shown in Figure 1A. All these investigations
were performed with the same version of FloTrac™system
software (V 1.03) in which the algorithm compensates for
changes in vascular resistance using a 10 minute moving
average. Obviously, this method may have difficulty
responding to rapid changes in vascular tone during
hemodynamic instability. Improvement regarding the
response time to changes in vascular tone has been
accomplished in a subsequent version of software
(V 1.07). The 10 minute moving window for assessing
vascular tone was set to a 1 minute moving window.
The estimation of COPAC has become the clinical stand-
ard, despite the fact that the method has limited accuracy
and may be affected by many factors such as ventilation,
volume and temperature of injectate, and technique of
indicator injection [24,25], which may have contributed
to the variations found between methods in the present
study. Differences of at least 15% in COPAC must be
achieved under clinical conditions for clinical relevance
when using the triplicate method [24,26]. Critchley and
Critchley demonstrated that errors of both test and refer-
ence method should be combined when assessing com-
parative CO, which results in a percentage error of ± 30%
to be clinically acceptable [23]. The percentage error of ±
49.3% between COPAC and COAP found in the present
study exceeded the recommended limit to accept a new
technique that has been compared to the reference
method.
Accuracy of CO assessment is an important issue and
should certainly be comparable between methods, but the
more relevant question for a clinician, operating with the
FloTrac™system in an ICU setting, concerns the value of
COAP assessment to reasonably detect the direction of
changes in CO under different hemodynamic conditions.
Trend analysis of percentage changes in CO between con-
secutive measurements (Figure 2A) demonstrates a mini-
mal bias between ΔCOPAC and ΔCOAP and LOA slightly
above the value suggested by Critchley and Critchley [23].
While the absolute values of CO did not show an exact
agreement between methods, the direction of changes in
COPAC assessment was obviously identified more precisely
by the FloTrac™system. However, to demonstrate that the
COAP algorithm correctly identifies changes in vascular
Table 2: Mean difference (bias) between intermittent thermodilution cardiac output (COPAC) and arterial pressure-based cardiac 
output (COAP) for all values (A) and for percentage changes between consecutive measurements of COPAC (ΔCOPAC) and COAP 
(ΔCOAP) (B) according to the modified approach by Bland and Altman for unequal numbers of replicates with upper and lower limits 
of agreement (bias ± 1.96 SD), together with 95% confidence intervals (in parentheses)
A COPAC [l/min] COAP [l/min] Bias (95% CI) [l/min] Upper limit of 
agreement (95%CI) [l/
min]
Lower limit of 
agreement (95%CI) 
[l/min]
5.93 ± 1.55 5.91 ± 1.15 0.02 (–0.40 to 0.44) 2.94 (1.81 to 4.07) –2.90 (–1.77 to 4.03)
B ΔCOPAC [%] ΔCOAP [%] Bias (95% CI) [%] Upper limit of 
agreement (95%CI) 
[%]
Lower limit of 
agreement (95%CI) 
[%]
0.91 ± 18.84 1.61 ± 17.08 –0.70 (–3.45 to 2.05) 31.58 (26.85 to 36.30) –32.98 (–37.70 to 
–28.26)
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tone, interventional studies are required in which the
FloTrac™system has to be compared to a continuous
measuring gold standard.
The range of cardiac outputs in the present investigation is
large, which should add power to our findings as all often
comparable studies were performed on hypodynamic
groups of patients. However, analysing the Bland-Altman
plot (Figure 1A), a slight trend for the FloTrac™system to
underestimate high CO values and to overestimate low
CO values could be observed. This should be taken into
account for further improvements of the algorithm.
Even though the FloTrac™system was designed as a screen-
ing tool in a segment of patients, who might have been
under-monitored before, any new CO device has to be
compared to the clinical gold standard of CO determina-
tion by the PAC in varying clinical situations before it
could be recommended for a broader application. Once
attached to a pre-existing arterial line, the device provides
additional information within 20 seconds without any
external calibration procedure, which may be valuable in
the care of an endangered patient. The advantages of the
device compared to other monitoring systems using the
arterial pressure for CO assessment are rationalized by its
simplicity and its lack of necessity for a time-consuming
placement of an additional catheter.
Limitations
The results of the present study are limited by the small
and varying number of CO estimations obtained for each
patient. However, even in this small group of patients, the
findings clearly demonstrate the limitations of the new
device and the need for improvements regarding the
response time to rapid changes in vascular tone. Further-
more, as changes in vascular tone have not been induced
in this investigation, additional interventional studies are
required to compare the latest version of FloTrac™software
to a continuous measuring gold standard regarding its
ability to correctly identify changes in arterial compliance.
Conclusion
FloTrac™system has the potential to be a promising alter-
native for cardiac output measurement, but the used algo-
rithm (V 1.03) failed to demonstrate an acceptable
accuracy in comparison to the clinical standard of CO
determination. Further studies are required to evaluate the
accuracy of this new device in various experimental and
clinical settings using the latest version of software.
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